To elucidate the mechanisms responsible for the increase in a,-adrenergic receptors during ischemia in vivo, we developed a procedure for measuring a,-adrenergic receptors in isolated, calcium-tolerant adult canine myocytes. Specific pH]prazosin binding was rapid, saturable, reversible, and demonstrated the expected order of potency and stereospecificity for the a,-adrenergic receptor. Myocytes exposed to 30 minutes of hypoxia at 25° C or only 10 minutes at 37° C exhibited a twofold to threefold increase in the number of a,-adrenergic receptors with no significant change in receptor affinity. This hypoxia-induced increase in receptor number was reversible by 10 minutes of reoxygenation at 37°C
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Guy P. Heathers, Kathryn A. Yamada, Evelyn M. Kanter, and Peter B. ConTo elucidate the mechanisms responsible for the increase in a,-adrenergic receptors during ischemia in vivo, we developed a procedure for measuring a,-adrenergic receptors in isolated, calcium-tolerant adult canine myocytes. Specific pH]prazosin binding was rapid, saturable, reversible, and demonstrated the expected order of potency and stereospecificity for the a,-adrenergic receptor. Myocytes exposed to 30 minutes of hypoxia at 25° C or only 10 minutes at 37° C exhibited a twofold to threefold increase in the number of a,-adrenergic receptors with no significant change in receptor affinity. This hypoxia-induced increase in receptor number was reversible by 10 minutes of reoxygenation at 37°C . In contrast, more prolonged hypoxia of 80 minutes or hypotonic shock actually decreased receptor number below normoxic, control values. The concentration of long-chain acylcarnitines in myocytes also increased threefold on exposure to 30 minutes of hypoxia. Sodium 2-[5-(4-chlorophenyl)-pentyl]-oxirane-2-carboxylate (POCA, 10 /AM), a potent inhibitor of carnitine acyltransferase I, not only abolished the accumulation of long-chain acylcarnitines but also the increase in a,-adrenergic receptor number induced by 30 minutes of hypoxia. Likewise, incubation of normoxic cells with exogenous palmltoyl carnitine (1 fiM) for 10 minutes also increased a,-adrenergic receptor number in the presence or absence of POCA. Thus, hypoxia results in an increase in a,-adrenergic receptors associated with an increase in endogenous long-chain acylcarnitines. Furthermore, inhibition of carnitine acyltransferase I prevents not only the sarcolemmal accumulation of long-chain acylcarnitines but also the exposure of the a,-adrenergic receptor, indicating that accumulation of endogenous long-chain acylcarnitines is critical to the hypoxia-induced increase in a,-adrenergic receptors on adult myocytes. {Circulation Research 1987;61:735-746) U nder physiologic conditions, the effects of catecholamines in the heart are mediated primarily through stimulation of /3-adrenergic receptors. Recent findings from a number of laboratories have identified an increase in a-adrenergic responsivity in ischemic myocardium. For example, nonspecific, a-adrenergic blockade with phentolamine or specific, a,-adrenergic blockade with prazosin decreases markedly the incidence of ventricular fibrillation and the frequency of premature ventricular complexes associated with coronary artery occlusion and/or reperfusion in the cat, 1 
"
3 dog,*" 7 pig, 6 and rat. 8 -9 a,-Adrenergic receptor number has been shown to increase markedly with ischemia in the cat, 10 dog," and guinea pig. 12 This increase in a,-adrenergic receptor number is reversible with sustained reperfusion 10 and correlates closely with the increase in 1 Several lines of evidence indicate that endogenous cardiac amphiphiles, including the structurally similar lysophosphoglycerides and long-chain acylcarnitines, increase during myocardial ischemia in vivo, 13 
17 and that comparable concentrations induce reversible electrophysiologic alterations in vitro, 16 " 22 analogous to those alterations seen in the ischemic heart in vivo. We have shown recently that hypoxia in isolated rat myocytes leads to a marked, preferential increase in sarcolemmal long-chain acylcarnitjnes assessed using electron microscopic autoradiography. 23 In addition, the electrophysiologic alterations resulting from hypoxia were prevented by precluding the sarcolemmal accumulation of long-chain acylcarnitines secondary to inhibition of carnitine acyltransferase I. 23 A preliminary study has been reported in which a,-adrenergic receptor density increased in adult rat myocytes exposed to hypoxia. 24 Therefore, the present study was performed to assess whether accumulation of longchain acylcarnitines contributed to the increase in a,-adrenergic receptors during hypoxia. The first portion of the study was performed to extensively characterize the a,-adrenergic receptors on isolated adult canine myocytes. Adult myocytes were used since responses to a,-adrenergic stimulation have been shown to differ in neonatal compared with adult tissue. 23 The second portion of the study was performed to assess whether hypoxia increased a,-adrenergic receptors and whether the increase was associated with
The percentage of elongated myocytes was improved considerably by separating elongated myocytes from contracted and rounded cells in a percoll gradient followed by a bovine serum albumin (BSA) gradient. The myocytes were suspended initially in 5.3 ml of 50 /iM Ca 2+ /HEPES with 1.4% BSA (pH 7.2), mixed with 4.7 ml isotonic percoll solution (4.23 ml percoll, 470 //.I 9% NaCl, 1 drop of 1 N acetic acid, pH 7.3), and centrifuged at 700g for 8 minutes. The bottom layer containing the elongated myocytes was placed on a BSA gradient (60 mg/ml, Sigma A4503 fraction V, 30 ml of 50 fj.M Ca 2+ /HEPES) and centrifuged at 50g for 5 minutes. The pellet was resuspended in 50 ( Ca 2+ /HEPES and washed once in the same medium. The Ca 2+ concentration of the myocyte preparation was brought up slowly by steps to 100 £im, 200 /im, 350 pirn, and finally 0.5 mM over 2 hours by addition of appropriate amounts of 10 mM Ca 2+ /HEPES every 30 minutes. The overall recovery of the myocyte preparation was 30-40% of the wet weight of the tissue. The myocytes were kept in the HEPES buffer at 0.5 mM [Ca 2+ ] at 25° or 37° C before and during experimental procedures.
Assessment of Myocyte Viability
Myocyte viability was assessed by a number of procedures. Morphologic analysis using light microscopy was routinely performed, viable myocytes being those that are elongated, with clear striations, sharp edges, and no blebs on the cell surface. Exclusion of trypan blue (0.05%) was also used as an indicator of cell viability. Biochemical analysis of cell viability included measurement of cytosolic enzyme release (lactate dehydrogenase, creatine kinase) and levels of high-energy phosphates (adenosine 5'-triphosphate [ATP], creatine phosphate). Lactate dehydrogenase was assayed by following the decrease in absorbance at 340 nm as pyruvate was reduced to lactate with coupled oxidation of nicotinamide adenine dinucleotide (reduced form, NADH). 27 Creatine kinase was assayed by the method of Oliver 28 and involves the production of ATP from creatine phosphate and adenosine 5'-diphosphate (ADP). The ATP generated by the creatine kinase reaction was utilized in a hexokinase/glucose 6-phosphate dehydrogenase coupled enzyme system, which ultimately yields an amount of reduced nicotinamide adenine dinucleotide phosphate (NADP) proportional to the activity of creatine kinase activity. The formation of reduced NADP was followed by absorbance at 340 nm. ATP was assayed by a modification of the method of Bucher. Phosphoglycerate kinase was used to catalyze the formation of ADP and 1,3-diphosphoglycerate from ATP and 3-phosphoglycerate. Glyceraldehyde phosphate dehydrogenase then catalyzes the formation of glyceraldehyde 3-phosphate and NAD from 1,3-diphosphoglycerate and NADH. The decrease in absorbance at 340 nm as NADH was oxidized to NAD is proportional to the ATP originally present in the sample. Creatine phosphate was assayed by forming ATP from creatine phosphate and ADP via creatine kinase. The ATP was subsequently assayed as outlined above, a method based on that of Fawaz and colleagues. 30 All assays were evaluated for linearity over the range used for this study and for recovery by the addition of exogenous ATP, creatine phosphate, lactate dehydrogenase, and creatine kinase. All recoveries are consistent and exceed 90% of the amount added. Assessments of myocyte viability were performed during the experimental time period as outlined in "Results." Morphologic assessments were performed on aliquots before and after the radioligand binding assay of normoxic and hypoxic cells. 
Measurements of Free, Short-Chain, and Long-Chain Acylcarnitines
To assess the concentration of long-chain acylcarnitine (acid insoluble) and short-chain acylcarnitine and free carnitine (acid soluble) a modified method of that described by McGarry and Foster 26 was utilized. The myocyte suspension (approximately 3 mg protein) was centrifuged at 3,000g for 7 seconds and the pellet quickly frozen in liquid N 2 . After thawing, 500 fi\ of distilled water was added and the contents transferred to a preweighed tube. Additonal distilled water was added to bring the contents to a total weight of 1 g. Two 25-/AI aliquots were taken for protein measurement. 35 The tubes were re weighed, and an equal amount (by weight) of 14% perchloric acid was added. The contents were homogenized with a Duall homogenizer and acid soluble and acid insoluble fractions were separated on Gelman GA 6 filters (0.45 fiM, 13 mm diameter) in a filter housing apparatus under vacuum in which the filtrate was collected. The filters were placed in a vial with 200 /AI of KOH (5 M) to hydrolyze the acid insoluble or long-chain acylcarnitine fraction. The filtrates were placed in a vial, and 800 fi\ of KOH (5 M) were added to hydrolyze the acid soluble fraction containing free and short-chain acylcarnitine. Both sets of vials were incubated at 80° C for 2 hours to hydrolyze acyl groups on the carnitine moiety. The vials were cooled on ice, and 200 fil of HEPES (1 M) were added to the filters and 800 fi\ to the filtrates. All samples received 50 /il of 70% perchloric acid, were vortexed, and an additional 70% perchloric acid added to attain a pH of 7.0. After cooling on ice for 30 minutes, the vial contents were filtered through Gelman A/E filters (0.3 fim, 13 mm) into preweighed vials, and the vials were reweighed.
The assay involves the conversion of all carnitine present in the acid soluble and acid insoluble fractions to [ l4 C]acetyl carnitine via carnitine acetyl transferase using ["CJacetyl CoA (New England Nuclear, Boston, Mass.). The reaction was driven to completion by the presence of excess N-ethyl maleimide (NEM). Three blanks (600 /xl distilled water), a standard curve (10 to 1,000 pmol /-carnitine in 600 /AI distilled water), and 200 /i.1 myocyte extract sample (with 400 /u.1 distilled water) were added to successive tubes. To each tube, 400 /xl of the following solution was added: HEPES 300 mM, EDTA 3 mM, NEM 5 mM, [ ]acetyl carnitine. Aquasol (New England Nuclear, 10 ml) was added to the resin eluate, and each vial was counted with quench correction using a Beckman LS 3801 liquid scintillation counter. A standard curve was constructed and linear regression analysis performed. The carnitine content of the acid soluble and insoluble fractions from myocyte preparations were determined from the calculated regression equation and expressed per milligrams protein. We and others have shown that the acid insoluble fraction contains exclusively acylcarnitines of chain lengths greater than 12 carbons, whereas the acid soluble fraction contains free carnitine and short-chain acylcarnitine with carbon chain lengths less than 12.
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Determination of the Influence of Exogenous LongChain Acylcarnitines on a,-Adrenergic Receptors
Myocytes (approximately 2-3 x 10* cells) were incubated with palmitoyl-/-carnitine (1 /iM) in HEPES buffer (0.5 mM Ca 2+ ; pH 7.2, total volume 8 ml) for 10 minutes at room temperature. When present, POCA (sodium 2-[5-(4-chlorophenyl)-pentyl]-oxirane-2-carboxylate) was added at a final concentration of 10 /xM. Immediately after 10 minutes incubation, the cells were assayed for specific [ 3 H]prazosin binding as described above.
Statistics
Significant differences in ATP and creatine phosphate content, lactate dehydrogenase (LDH) and creatine kinase (CK) release, a,-adrenergic receptor number (B^) and affinity (K d ), and differences in long-chain acylcarnitine levels were assessed by analysis of variance and the Tukey-Kramer multiple comparisons test. 37 The criterion for statistical significance wasp<0.05. All values are expressed as mean ± SEM. For the statistical determination of difference between the EC,,, values of different adrenergic agonists and antagonists, Eadie Hofstee plots were constructed from the displacement curves and an analysis of covariance performed between the EC W values obtained from the slopes, followed by the Tukey-Kramer multiple comparisons test. 37 
Results
Assessment of Myocyte Viability Over Time During Normoxia and Hypoxia
Electrophysiologic measurements were obtained using intracellular microelectrodes from myocytes that appeared elongated, striated, and had no blebs on the cell surface. Resting membrane potentials were found to be -87 ± 2 mV, the action potential duration at 95% of full repolarization was 293 ± 17 msec, and the Vŵ as 150 ±7 V/sec (n=13). The percentage of elongated and striated myocytes assessed morphologically using light microscopy were approximately 85% immediately after myocytes were suspended in the 0.5 mM [Ca 2+ ] HEPES buffer (pH 7.2). After two hours at 25° C, the percentage of viable myocytes had fallen slightly to approximately 80%. The corresponding figures for the percentage of myocytes excluding 0.05% trypan blue was 88 to 93% at time 0 and 81 to 88% after two hours. No difference was seen if the myocytes were kept at 37° C. The cellular content of high-energy phosphates, ATP and creatine phosphate, and the release of LDH and CK into the media as a function of time at 25° C in normoxic HEPES buffer are shown in Figure 1 . ATP content remained constant over the 2-hour normoxic interval, whereas creatine phosphate content decreased slightly but not significantly from 70 ± 15 to 52 ±7 nmol/mg protein. At 37° C, no significant differences between those values at 25° C were seen, the corresponding values for ATP being 63 ±3 at time 0 and 61 ±5 nmol/mg protein 2 hours later and for creatine phosphate, 63 ± 5 and 52 ± 4 nmol/mg protein at time 0 and 2 hours, respectively. There were no significant changes in the release of LDH or CK over the 2-hour normoxic time interval (Figure 1 ). Ten minutes after the myocytes were suspended in hypoxic HEPES buffer (Po 2 10 to 15 mm Hg) at 25° C, the content of ATP and creatine phosphate decreased markedly to 35 ±5 nmol/mg protein and 29 ±6 nmol/mg protein, respectively. Further significant decreases in ATP and creatine phosphate content occurred after 30 and 80 minutes of hypoxia (Figure 1 ). Increased release of LDH and CK indicating irreversible cellular disruption was not evident after 30 minutes of hypoxia at 25° C but was evident after 80 minutes of hypoxia when LDH release was 42 ± 4% and CK release was 54 ± 9% of total enzyme activity.
In separate paral lei experiments, the extent of release of LDH and CK over time during the hypoxic interval was determined at both 25° and 37° C (Figure 2 ). There was an initial modest decrease in enzyme release between the initiation of hypoxia and the 10-minute time point. This is the result of the normoxic HEPES buffer being replaced with hypoxic buffer under a nitrogen atmosphere to initiate the hypoxic interval. Therefore, statistical analysis to determine differences in enzyme release over the hypoxic time interval was performed using the 10-minute time point as the control value. At 25° C a significant increase in LDH activity in the extracellular buffer occurred after 80 minutes of hypoxia whereas at 37° C increased LDH release occurs more rapidly with a significant increase after only 40 minutes of hypoxia. Similar, although not identical, time intervals of hypoxia were required for the release of CK activity into the buffer. Thus, marked irreversible membrane damage is evident after 70 minutes of hypoxia at 25° C or 30 minutes of hypoxia at 37° C (Figure 2 ).
Morphologic assessment of the myocytes also revealed that 30 minutes of hypoxia at 25° C was associated with a modest fall in viability (67-71% elongated and excluding trypan blue), whereas a marked decline in viability was evident at 80 minutes of hypoxia (30-45% elongated and excluding trypan blue). In contrast, hypoxia for only 30 minutes at 37°C resulted in a marked decline in viability (25-36%), whereas no decrease in viability was seen after 10 minutes of hypoxia at 37° C (70-79%).
Cellular ATP and creatine phosphate fell more sharply during hypoxia at 37° C than at 25° C such that by 10 minutes, ATP had fallen to 22 ±6 nmol/mg protein at 37° C compared to 35 ± 5 nmol/mg protein at 25° C ( Figure 3 ). Similar changes were seen in cellular creatine phosphate content. Indeed, ATP and creatine phosphate after 30 minutes of hypoxia at 37°C had fallen to levels similar to that seen after 80 minutes of hypoxia at 25° C (Figure 3) .
Thus, irreversible cell damage induced by hypoxia as indicated by release of cytosolic enzymes, very low high-energy phosphate levels, and morphologic derangements occurred after 70 to 80 minutes at 25° C and after 30 to 40 minutes at 37° C. Myocytes that had been exposed to a hypotonic medium (HEPES buffer without sodium chloride or sucrose) for 30 minutes exhibited similar characteristics to those which had undergone prolonged hypoxia. Morphologic assessment revealed no elongated striated myocytes (all rounded cells); LDH activity in the supernatant was 70% of total; CK release was 76%; ATP content was 36 ±4 nmol/mg protein and creatine phosphate content was 28 ±7 nmol/mg protein.
Characteristics of [ 3 H]Prazosin Binding to Intact Myocytes
Total, specific, and nonspecific binding of [ 3 H]prazosin to adult canine myocytes is shown in Figure 4 . Figure 6 . The displacement paralleled the expected order of potency and stereospecificity for the a,-adrenergic receptor. The displacement curves were analyzed by EBDA, a program written for computer analysis of competition studies.
3 * The concentration of agonists or antagonists producing 50% displacement (EC,,,), the calculated binding constant K,, and the Hill coefficient (n H ) are shown in Table 1 . The specific a,-adrenergic antagonists prazosin (EC j ,, 0.75 nM) and hydroxyethylaminomethyl tetralone (HEAT or BE-2254, EC^ 23 nM) were considerably more potent at displacing specifically bound [ 3 H]prazosin than the a 2 -adrenergic antagonist yohimbine (EC,,, 1,010 nM). The nonspecific a-adrenergic antagonist phentolamine (EC,,, 344 nM) was more potent than yohimbine, but less potent than the a,-adrenergic antagonists ( 
FIGURE 6. Displacement of specific ['Hjprazosin binding on adult myocytes by adrenergic antagonists (top) and agonists (bottom). The concentration of ['Hjprazosin was 0.3 nM. Percent displacement of specific binding is shown on the ordinate and each curve represents the displacement induced by different agonists and antagonists at increasing concentrations shown on the abscissa. Each point represents the mean ± SEM of 3 determinations.
of magnitude more potent than the /3-adrenergic agonist /-isoproterenol (EC W was assessed from the displacement curve as the EBDA program could not calculate an EC,,, that was approximately 1.2 mM). All Hill coefficients were not significantly different from unity, indicating the absence of cooperative interactions.
Influence of Hypoxia on a,-Adrenergic Receptors
Hypoxia was produced by suspending the myocyte preparation in 1 mM glucose/HEPES buffer (pH 7.2) with a Po 2 between 10 and 15 mm Hg. This was achieved by gassing the HEPES buffer with 100% purified N 2 for 2 hours and transferring an appropriate volume of this solution, in an air-tight apparatus, to the myocyte preparation under a N 2 atmosphere.
Typical Scatchard plots of specific [ 3 H]prazosin binding to normoxic myocytes and those exposed to hypoxic conditions for 30 minutes at 25° C are shown in the inset in Figure 4 , and mean values (n = 8) are given in Table 2 . Hypoxia of 30 minutes duration at 25° C led to a marked increase in B^, from 1.93 ± 0.18 to 5.42±0.68 fmol/mg protein (p<0.01), with no significant change in receptor affinity. The extent of myocyte viability after 30 minutes of hypoxia at 25° C was similar to that seen in normoxic myocytes as assessed by morphologic and biochemical criteria (see above). In contrast, hypoxia of 80 minutes duration at 25° C, a time interval that led to a marked reduction in the number of elongated myocytes and increased LDH and CK release (Figures 1 and 2 ), resulted in a modest decrease in receptor number to 1.35 ±0.21 fmol/mg protein (p<0.0l compared with control myocytes, Table 2 ). A similar decrease in receptor number and viability occurred after exposure of myocytes to a hypotonic medium ( Table 2) .
The data presented in Figure 2 suggested that irreversible cell damage during hypoxia, assessed by enzyme release into the buffer surrounding the cells, began to occur more rapidly at 37° C than at 25° C. Accordingly, a,-adrenergic receptors were measured after 10 minutes of hypoxia at 37° C to assess the effects of hypoxia at this more physiologic temperature (Table  3) . At 10 minutes, receptor number increased over twofold from control, normoxic values of 1.90±0.25 fmol/mg protein to hypoxic values of 4.15 ±0.55 (p<0.0\), with no change in receptor affinity (Table  3 ). In addition, 10 minutes of reoxygenation at 37° C after 10 minutes of hypoxia resulted in a return of the receptor number to control normoxic values (1.99±0.32 fmol/mg protein, p<0.01 compared with hypoxic values, Table 3 ).
The concentration of long-chain acylcarnitines in the myocyte preparation increased threefold during 30 minutes of hypoxia at 25° C, from normoxic levels of 21.3±2.5 to 66.2± 13.3 pmol/mg protein (p<0.01, Figure 7 , Table 4 ). Although the level of short-chain acylcarnitine and free carnitine decreased modestly, 951 ± 113 to 866 ± 190 pmol/mg protein, this change did not achieve statistical significance (Table 4) . Pretreatment of cells with POCA (10 /nM), a specific and potent inhibitor of carnitine acyltransferase I, completely abolished not only the increase in longchain acylcarnitines induced by hypoxia (Table 4) , but also prevented the increase in a,-adrenergic receptor number, seen after 30 minutes of hypoxia at 25° C (Table 2 and Figure 7) . Pretreatment with POCA also prevented the increase in a,-adrenergic receptor number seen after 10 minutes of hypoxia at 37° C (Table 3) . Thus, inhibition of carnitine acyltransferase I with POCA blocked both the increase in a,-adrenergic receptor number and the increase in long-chain acylcarnitine levels induced by hypoxia. Indeed, the magnitude of the increase in a,-adrenergic receptor density under hypoxic conditions parallels closely the magnitude of the change in the cellular concentration of long-chain acylcarnitines (Figure 7) .
Influence of Exogenous Long-Chain Acylcarnitines on a,-Adrenergic Receptors
To exclude an effect of POCA per se on [ 3 H]prazosin binding to hypoxic myocytes, independent of inhibition of carnitine acyltransferase I, an additional series of studies were performed. These studies consisted of assessing whether exogenous long-chain acylcarnitines, in the presence or absence of POCA (10 /xM), would lead to an increase in a,-adrenergic receptor density in normoxic myocytes. Incubation of myocytes under normoxic conditions with palmitoyl carnitine (1 /JLM) for 10 minutes led to a significant increase in receptor density in the presence or absence of POCA (Table 5 ). The K^ also increased in the presence of exogenous long-chain acylcarnitine (Table 5) . Thus, exogenous acylcarnitines led to an increased exposure of a,-adrenergic receptors in intact normoxic myocytes, despite pretreatment with POCA.
Discussion
Recent results from our laboratory and others have demonstrated that the arrhythmogenic effects of catecholamines in the ischemic and reperfused heart can be mediated through stimulation of not only /3-adrenergic, but also a,-adrenergic receptors.'" 9 We have reported previously that ischemia in vivo results in an increase in a,-adrenergic receptor number in membrane fractions derived from the ischemic region, an effect that is reversible with sustained reperfusion. 10 Similar findings have been reported in the dog 1 ' and guinea pig 12 in response to ischemia. However, the mechanisms responsible for the increase in a,-adrenergic receptor number during ischemia are unknown. The findings of the present study indicate that sarcolemmal accumulation of long-chain acylcarnitines during hypoxia can mediate an increase in a,-adrenergic receptor number on adult canine myocytes. This mechanism may contribute to the increase in a.-adrenergic receptors and, in turn, enhanced a,-adrenergic responsivity in ischemic myocardium in vivo. The major findings that support this conclusion include: 1) hypoxia leads to a marked increase in a,-adrenergic receptor density; 2) the increase in receptor density is reversible after short periods of reoxygenation; 3) the increase in receptor density is associated with a threefold increase in long-chain acylcarnitines; 4) inhibition of carnitine acyltransferase I with POCA prevented not only the increase in long-chain acylcarnitines but also the increase in a,-adrenergic receptor number; and 5) exogenous delivery of long-chain acylcarnitine, in the presence or absence of POCA, in normoxic cells led to an analogous increase in a,-adrenergic receptor number on isolated adult myocytes. This latter finding indicates that the effect of POCA to prevent the increase in a,-adrenergic receptor density during hypoxia is not mediated by a nonspecific effect of POCA to interfere with binding of [ 3 H]prazosin to the surface a,-adrenergic receptor.
Previous studies designed to characterize the potential alterations in a,-adrenergic receptors in response to ischemia have been performed using membrane preparations derived from ischemic tissue. These procedures, by necessity, involve homogenization of myocardial and nonmyocardial tissue and subsequent separation of membrane-enriched fractions. This approach does not permit discrimination between myocardial and nonmyocardial cellular elements. To overcome these difficulties, we developed an adult canine myocyte preparation with intact sarcolemma, devoid of nonmyocardial tissue, to investigate the mechanisms responsible for the increase in a,-adrenergic receptors. The procedures developed for isolation of adult canine myocytes gave consistently good yields and viability as determined by morphologic, biochemical, and electrophysiologic criteria. Intracellular recordings from elongated myocytes revealed resting membrane potentials of -87 mV and normal transmembrane action potentials, with V^ of phase 0 in the order of 150 V/sec, values similar to those reported by others in intact epicardial tissue slices from the dog."
The cellular contents of ATP and creatine phosphate measured during control incubation for two hours at 25°o r 37° C were comparable to or slightly higher than those reported by others in myocyte preparations 40 '' 2 and comparable to that in perfused hearts. 43 In addition, the release of lactate dehydrogenase and creatine kinase over time during normoxia is similar to the values reported by others 4144 and below 15% of total enzyme activity. The onset of irreversible cell injury occurred considerably earlier at 37° C and correlated with a more marked fall in the levels of ATP and creatine phosphate than was seen at 25° C. Piper and colleagues, 42 using adult rat myocytes, found that ATP and creatine phosphate levels decreased rapidly after the onset of hypoxia (20 minutes), although not quite as rapidly as in the present study, and increased release of LDH activity occurred at 30 minutes of hypoxia at 37° C, observations comparable with those reported in this study. In addition, Smith and colleagues 43 found that a fall in the Po 2 of the solution bathing chick myocytes to below 12 mm Hg resulted in a rapid decline in the spontaneous beating rate after 10 minutes at 37° C. Evidence was provided to suggest that at this Po 2 , the rapid decline in contractions resulted from a rapid decrease in high-energy phosphates. Reoxygenation after 10 minutes of hypoxia at 37° C was accompanied by a rapid return to control rates of beating, suggesting no irreversible membrane damage had occurred, 43 comparable to our findings in the present study.
Specific 4 * However, these results were obtained with very low specific binding (20 to 30%), which may explain the relatively low affinity for the receptor compared with that in the present study. In addition, the purified sarcolemmal preparation will result in a large increase in B^ due to the large increase in amount of receptor protein per total cellular protein compared with that found in intact, functional myocytes. Intact myocytes from adult rats have a higher density of a,-adrenergic receptors, 76.7 ± 11.1 fmol/mg protein, and a higher affinity, K d 0.16 ±0.08 nM/ 7 than in the present study. The greater affinity of the receptor may be due to either species differences or secondary to cell lysis. In the present study, cell lysis induced by hypotonic shock resulted in an increase in receptor affinity. This suggests that disruption of the cell results in changes in receptor conformation and ability to interact with ligands. Indeed, Skomedal and colleagues 47 reported that in a rat myocyte preparation, two populations of a,-adrenergic receptors are present with different binding affinities. Muntz and colleagues 48 found a B^ value of 59.1 fmol/mg protein and K d of 0.26 nM using [H]prazosin binding in tissue slices from rat hearts, an affinity constant nearly identical to that found in the present study.
Specific [
3 H]prazosin binding to myocytes after a period of hypoxia of 30 minutes at 25° C, or only 10 minutes at 37° C, resulted in a twofold to threefold increase in receptor number compared with control, normoxic values. Thus, at the physiologic temperature of 37° C, a very rapid increase in receptor number was seen. These time intervals were associated with low ATP and creatine phosphate levels but there was no increased release of LDH or CK activities and no discernible morphologic derangements, indicating the absence of any sarcolemmal disruption. The rapid reversibility of the increase in a,-adrenergic receptor number induced by hypoxia was demonstrated by the return to control B mM values after reoxygenation at 37° C.
In contrast, more prolonged hypoxia of 80 minutes at 25° C or cell lysis by incubation in a hypotonic medium resulted in a decrease, rather than an increase, in a,-adrenergic receptor number compared with control values. With these interventions, the percentage of elongated, striated cells, assessed morphologically and by release of cytoplasmic enzymes, was below 40%. Thus, irreversible disruption of the cell does not lead to increased exposure of latent a,-adrenergic receptors. Maisel and colleagues 49 have shown a translocation, during ischemia in the guinea pig heart, of /3-adrenergic receptors from an intracellular light vesicle fraction to the sarcolemmal fraction. They have reported preliminary data 12 suggesting that this translocation does not occur for the a,-adrenergic receptor, despite the fact that there was a marked increase in a,-adrenergic number in sarcolemmal fractions from ischemic tissue. These findings suggest that the increase in a,-adrenergic receptors seen with short periods of hypoxia in the present study are due to exposure of latent a,-adrenergic receptors within, or closely associated with, the sarcolemma. The fact that our previous study demonstrated, using electron microscopic autoradiography, a preferential increase in sarcolemmal long-chain acylcarnitines during hypoxia in isolated myocytes, 23 indicates that the insertion of this amphiphile into the sarcolemma of an intact cell may be the critical mechanism responsible for the exposure of the a,-adrenergic receptor. This conclusion is also supported by the finding that exogenous palmitoyl carnitine, which would readily incorporate into the sarcolemma, also resulted in an increased density of the a,-adrenergic receptor in normoxic cells.
Fluidity is an inherent property of membranes, the alteration of which affects the accessibility of surface receptors to ligand binding. 50 For example, methylation of phosphatidylethanolamine to phosphatidylcholine increases membrane fluidity and concurrently increases the number of binding sites for the /3-adrenergic ligand [ 3 H]dihydroalprenolol in ratreticulocytes. 31 Conversely, phospholipase A 2 , which results in the production of lysophosphoglycerides, reduces [ 3 H]dihydroalprenolol binding. 52 During these experiments de novo synthesis of new receptors was not possible; the appearance of new receptors was probably due to alteration in membrane charge or microenvironment of the membrane surrounding the receptor. 31 Thus, accumulation of long-chain acylcarnitines in the sarcolemma with subsequent alterations in sarcolemmal fluidity and the microenvironment surrounding the receptor is the likely mechanism responsible for the increased exposure of a,-adrenergic receptors, by unmasking latent receptors closely associated with the sarcolemma.
Based on data derived from multiple cell systems, cell surface receptors to hormones, including catecholamines, are regulated through synthesis, internalization, externalization, recycling, and degradation. Since protein synthesis of new receptors and subsequent transfer and external ization to the surface of the sarcolemma obviously requires an extended period of time, the exposure of a,-adrenergic receptors in response to 10 minutes of hypoxia at 37° C is probably not mediated by this process. This conclusion is also supported by the data demonstrating that exogenous exposure to long-chain acylcarnitines for only 10 minutes leads to a comparable increase in a,-adrenergic receptors. The increase in long-chain acylcarnitines in hypoxic myocytes occurs to a significant extent in the sarcolemma based on our recent findings using electron microscopic autoradiography. 23 The resultant membrane perturbations induced by insertion of this amphiphile into the sarcolemma could lead to increased exposure or external ization of the a,-adrenergic receptor protein. The question of whether this exposed a,-adrenergic receptor is actually coupled to intracellular events by production of inositol trisphosphate from phosphatidylinositol 4,5-bisphosphate and capable of mediating a physiologic response in response to catecholamines is presently under investigation.
The possibility that stimulation of this externalized receptor during myocardial ischemia and early reperfusion leads to an increase in cytosolic calcium is supported by our findings demonstrating that a,-adrenergic blockade attenuates markedly the increase in cytosolic calcium during reperfusion of reversible injured tissue." Likewise, attenuation of the a,-adrenergic mediated increase in cytosolic Ca 2+ during reperfusion leads to a marked reduction in the extent of ultimate cellular necrosis. 54 Thus, under pathophysiologic conditions, such as acute myocardial ischemia, stimulation of the externalized a,-adrenergic receptor may lead to a mobilization and net increase in cytosolic calcium.
The recently demonstrated antiarrhythmic effect of inhibition of carnitine acyltransferase I with POCA in vivo during ischemia 33 is likely mediated not only by prevention of the direct electrophysiologic effects of accumulating long-chain acylcarnitines," but possibly by blockade of the increase in a,-adrenergic receptors during the time course of ischemia.
In summary, the present findings indicate, for the first time, one mechanism responsible for the increase in a,-adrenergic receptors during hypoxia in intact myocytes. The question of whether this mechanism is also operative during ischemia in vivo and whether the newly exposed receptor is coupled to breakdown of phosphatidylinositol requires investigation. Whether stimulation of the /3-adrenergic receptor under ischemic conditions, leading to intracellular lipolysis, increased free fatty acids and in turn, enhanced production of long-chain acylcarnitines and enhanced externalization of the a,-adrenergic receptor should also be a focus of investigation.
